Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 5:17:1225-1235.
doi: 10.2147/IJWH.S506075. eCollection 2025.

Platelet Count and Platelet Hematocrit Correlate to the Occurrence and Postoperative Recurrence in Intrauterine Adhesion Patients

Affiliations

Platelet Count and Platelet Hematocrit Correlate to the Occurrence and Postoperative Recurrence in Intrauterine Adhesion Patients

Yuhui Wei et al. Int J Womens Health. .

Abstract

Background: Platelet count (PLT) has been identified as a predictor for the development of pelvic adhesions. However, it remains unclear whether platelet-related parameters can also serve as indicators for the occurrence of intrauterine adhesions (IUA).

Methods: Patients diagnosed with IUA were included for further analysis, with platelet-related parameters assessed through routine blood tests. The predictive value of PLT and platelet hematocrit (PCT) was evaluated using receiver operating characteristic (ROC) curve analysis. Recurrence of IUA was determined based on a one-year follow-up.

Results: Our study included 69 IUA patients and 60 matched healthy women. We found that PLT and PCT levels were significantly elevated in IUA patients compared to the healthy controls. ROC analysis demonstrated that both PLT and PCT effectively predicted the occurrence of IUA. Additionally, higher PLT and PCT levels were noted in patients with recurrent IUA, suggesting their potential for predicting recurrence.

Conclusion: Elevated PLT and PCT levels were observed in patients with IUA and were further increased in those with recurrent cases. These findings suggest that high PLT and PCT levels may serve as valuable predictors for both the occurrence and recurrence of IUA. Specifically, the study is limited by the small sample size of recurrent IUA cases and potential confounders. These limitations should be considered when interpreting the findings.

Keywords: intrauterine adhesions; occurrence; platelet; platelet crit; recurrence.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interest to declare in this work.

Figures

Figure 1
Figure 1
Comparisons of platelet count (PLT, (A)), platelet crit (PCT, (B)), mean platelet volume (MPV, (C)), and platelet distribution width (PDW, (D)) between women with intrauterine adhesions (IUA) and health control. Box plot was used to show the data, and p values were calculated by Unpaired t-test with Welch’s correction.
Figure 2
Figure 2
ROC analysis for the diagnostic values of PLT and PCT and their combined test for intrauterine adhesions (IUA).
Figure 3
Figure 3
Comparisons of platelet count (PLT, (A)), platelet crit (PCT, (B)), mean platelet volume (MPV, (C)), and platelet distribution width (PDW, (D)) of women with intrauterine adhesions (IUA) who had postoperative recurrence (RC, n = 21) or non-recurrence (NRC, n = 48) during the one year of follow-up after the surgery. Box plot was used to show the data, and p values were calculated by Unpaired t-test with Welch’s correction.
Figure 4
Figure 4
ROC analysis for the predictive values of PLT and PCT and their combined test for recurrence during the one-year follow-up after the surgery in intrauterine adhesions (IUA) patients.
Figure 5
Figure 5
Comparisons of platelet count (PLT, (A)), platelet crit (PCT, (B)), mean platelet volume (MPV, (C)), and platelet distribution width (PDW, (D)) at the time of admission and recurrence in women with intrauterine adhesions (IUA) who had postoperative recurrence (RC, n = 21) during the one year of follow-up after the surgery. A box plot was used to show the data, and p values were calculated by paired t-test.

Similar articles

References

    1. Tang R, Xiao X, He Y, Qiu D, Zhang W, Wang X. Clinical evaluation of autologous platelet-rich plasma therapy for intrauterine adhesions: a systematic review and meta-analysis. Front Endocrinol). 2023;14:1183209. doi:10.3389/fendo.2023.1183209 - DOI - PMC - PubMed
    1. Ang CJ, Skokan TD, McKinley KL. Mechanisms of regeneration and fibrosis in the endometrium. Annu Rev Cell Dev Biol. 2023;39:197–221. doi:10.1146/annurev-cellbio-011723-021442 - DOI - PMC - PubMed
    1. Khan Z. Etiology, risk factors, and management of asherman syndrome. Obstet Gynecol. 2023;142(3):543–554. doi:10.1097/AOG.0000000000005309 - DOI - PubMed
    1. Wu F, Lei N, Yang S, et al. Treatment strategies for intrauterine adhesion: focus on the exosomes and hydrogels. Front Bioeng Biotechnol. 2023;11:1264006. doi:10.3389/fbioe.2023.1264006 - DOI - PMC - PubMed
    1. Lee WL, Liu CH, Cheng M, Chang WH, Liu WM, Wang PH. Focus on the primary prevention of intrauterine adhesions: current concept and vision. Int J Mol Sci. 2021;22(10):5175. doi:10.3390/ijms22105175 - DOI - PMC - PubMed

LinkOut - more resources